Adi Joshi (IMAGE)

Texas A&M University

Adi Joshi

Caption

Dr. Adi Joshi and his research team are investigating MAP4K4 as a therapeutic target for MASH, a progressive form of fatty liver disease.

Credit

Texas A&M University

Usage Restrictions

use with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.